APA

Rayson D., Suter T. M., Jackisch C., van der Vegt S., Bermejo B., van den Bosch J., Vivanco G. L., van Gent A. M., Wildiers H., Torres A., Provencher L., Temizkan M., Chirgwin J., Canon J. L., Ferrandina G., Srinivasan S., Zhang L. & Richel D. J. (20121022). Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Rayson D, Suter T M, Jackisch C, van der Vegt S, Bermejo B, van den Bosch J, Vivanco G L, van Gent A M, Wildiers H, Torres A, Provencher L, Temizkan M, Chirgwin J, Canon J L, Ferrandina G, Srinivasan S, Zhang L and Richel D J. 20121022. Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Rayson D., Suter T. M., Jackisch C., van der Vegt S., Bermejo B., van den Bosch J., Vivanco G. L., van Gent A. M., Wildiers H., Torres A., Provencher L., Temizkan M., Chirgwin J., Canon J. L., Ferrandina G., Srinivasan S., Zhang L. and Richel D. J. (20121022). Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Rayson D, Suter T M, Jackisch C, van der Vegt S, Bermejo B, van den Bosch J, Vivanco G L, van Gent A M, Wildiers H, Torres A, Provencher L, Temizkan M, Chirgwin J, Canon J L, Ferrandina G, Srinivasan S, Zhang L and Richel D J. Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20121022.